Matching Your Gift Dollar for Dollar
The Salk Institute is recruiting a new Assistant Professor, Dr. Christina Towers, to the Salk Cancer Center. In honor of the Conquering Cancer Initiative, the BioMed Realty Management Team is issuing a challenge match – they will match, dollar for dollar, up to $1M, to support Towers’ recruitment and to support her research and that of the Salk Cancer Center. BioMed’s president and CEO, Tim Schoen, is a Salk trustee and chairman of the Institute’s Conquering Cancer Initiative Advisory Committee.
Everyone knows someone impacted by cancer. One in two men and one in three women will be diagnosed with cancer in their lifetime. Worldwide, cancer rates are expected to increase by as much as 63 percent by 2040.
Current therapies remain insufficient to address the threat. Through innovative biomedical expertise and collaborations, the Salk Cancer Center is working to develop new therapies and cures to enhance the lives of current and future generations.
Salk’s Conquering Cancer Initiative is a scientific and philanthropic initiative to bring together scientists in collaboration to harness new strategies against five deadly cancers: pancreatic, ovarian, lung, brain (glioblastoma) and triple negative breast. Together, Salk researchers will identify cancer’s vulnerabilities and find new methods to attack tumors and leave healthy tissues alone. Our Conquering Cancer Initiative launched in April 2018 and we are pleased to share our Year Two Progress report thanks to supporters and collaborators who serve as our valued partners.
We are at a unique and momentous time in cancer research. We invite you to be a part of our Conquering Cancer Initiative.
Thank you for attending the recent Salk Institute program: The Power of Science: Conquering Pancreatic Cancer. Below is the link to the program recording and also two additional videos and the research being done on colon cancer.
If you would like to make a gift to the Salk Pancreatic Cancer Program, please visit this online giving link.
November 16, 2020
Colon Cancer Research at Salk – Ronald Evans, PhD – http://www.salk.edu/pr2019-02-21
Sandy Liarakos, CFRE
Senior Director of External Relations
Bench to Bedside to Bench Lecture Series
Date: Wednesday, March 17, 2021
Time: 12:00 p.m.
Talk title: Treatment Response and Resistance in Molecularly Defined Cohorts of Lung Cancer
Speaker: Christine M. Lovly, MD, PhD
Associate Professor of Medicine
Division of Hematology-Oncology
Ingram Associate Professor of Cancer Research
Vanderbilt University Medical Center
Vanderbilt Ingram Cancer Center
Hosts: Ed Stites, MD, PhD, Assistant Professor
Reuben Shaw, PhD, Director, Salk Cancer Center
Contact: Leona Flores, PhD, email@example.com
Did you know that Salk Cancer Center has been leading the way in conquering cancer since 1970? Find Out How »
Introduction by Cancer Center Director, Reuben Shaw
Panel discussion with Ronald Evans, Tony Hunter and Dannielle Engle
April 20, 2018 – Highlights from Keynote Presentation by Joseph R. Biden, Jr.